ELOBP2

Across TCGA pan-cancer cohorts, ELOBP2 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated ELOBP2 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ELOBP2 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated ELOBP2 expression acts as an unfavorable survival marker, although some lineages such as CESC and COAD show a favorable association.

CESC, OV, and COAD are the cancer types where ELOBP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	DFS	Median	All	0.831	0.644	<.001	74	view →
OV	DFS	Tertile	All	0.310	0.406	.005	56	view →
COAD	OS	Median	III,IV	0.869	0.677	.006	51	view →
LUAD	OS	Median	III,IV	0.251	0.686	<.001	48	view →
ACC	DFS	Median	III,IV	0.275	0.734	<.001	36	view →
LIHC	OS	Median	All	0.612	0.786	<.001	28	view →
LUSC	OS	Tertile	All	0.714	0.563	.004	21	view →
UVM	DFS	Median	All	0.593	0.846	.009	16	view →
LGG	DFS	Median	All	0.351	0.435	.011	15	view →
THYM	DFS	Median	II,III,IV	1.000	0.418	.002	13	view →
KIRP	OS	Median	All	0.592	0.765	.005	13	view →
KIRC	DFS	Median	III,IV	0.842	0.637	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

ELOBP2–CESC (DFS)

Open the CESC breakdown →